Craig Boerner

August 2, 2022

VUMC, Harvard Medical School named to join AMAF consortium to address LGBTQ+ health disparities

Vanderbilt University Medical Center and Harvard Medical School will participate in the American Medical Association Foundation National LGBTQ+ Fellowship Program consortium of institutions.

By Craig Boerner
July 28, 2022

Study to evaluate nasal flu vaccine for children

Pediatricians with the Vanderbilt Vaccine Research Program are looking for healthy infants and children (6 months – 8 years of age) to take part in a nasal influenza vaccine study.

By Craig Boerner
Dolly Parton and longtime friend, Naji Abumrad, MD. (photo Courtesy of Dolly Parton)
June 15, 2022

Dolly Parton donates $1 million to pediatric infectious disease research at Vanderbilt University Medical Center

Dolly Parton is donating $1 million to pediatric infectious disease research at Vanderbilt University Medical Center to help in the fight against serious infectious diseases such as coronavirus that have worldwide ramifications.

By Craig Boerner
The TOWAR team includes, from left, Sadia Laghari, MLS(ASCP); Mayur Patel, MD, MPH; Ashley Panas, MD, MPH; Allan B. Peetz, MD, MPH; Christy Kampe MAcc, CCRP, CIP; and April Johnson.
June 1, 2022

Trauma study aims to improve survival for bleeding patients

Emergency Medicine and Trauma Surgery researchers at Vanderbilt University Medical Center are joining Vanderbilt LifeFlight in a Department of Defense (DOD)-funded clinical trial aimed at improving survival with resuscitation techniques used to keep patients alive after a traumatic injury.

By Craig Boerner
April 28, 2022

Care access pathways similar for young Black and white athletes in concussion network

Vanderbilt research found that both Black and white young athletes who suffered concussions while within a sport-related concussion (SRC) clinic referral did not experience health disparities related to their care.

By Craig Boerner
VUMC’s ECMO program has expanded to areas outside of the Cardiovascular Intensive Care Unit.
February 25, 2022

Study shows young, healthy adults died from COVID-19 due to ECMO shortage

Vanderbilt research found that nearly 90 percent of COVID-19 patients who qualified for, but did not receive, ECMO due to a shortage of resources during the height of the pandemic died in the hospital, despite being young with few other health issues

By Craig Boerner
February 7, 2022

Study shows lifesaving benefit of baricitinib for ventilated COVID patients

Vanderbilt research shows that critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation lived more often when randomized to receive baricitinib.
By Craig Boerner
February 3, 2022

Study finds shorter treatment better for young children with outpatient pneumonia

A Vanderbilt study found that five days of antibiotics is superior to 10 days for children with community-acquired pneumonia who are not hospitalized.
By Craig Boerner
December 6, 2021

Potential Rett syndrome drug shows promising results in phase 3 trial

A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.
By Craig Boerner
November 17, 2021

Case to depart role as Chief Compliance Officer

Vanderbilt University Medical Center Chief Compliance Officer Edward (Ted) Case, JD, is leaving VUMC to return to private law practice.
By Craig Boerner
September 9, 2021

Raman, Balucan receive health equity research grants

Vanderbilt researchers Rameela Raman, PhD, and Francis Balucan, MD, MBA, are the recipients of the first annual Vanderbilt Center for Health Services Research (CHSR) Health Equity Research Grants.
By Craig Boerner
July 26, 2021

VUMC, NIH launch clinical trial to test novel therapies to protect host tissue against COVID-19

Vanderbilt University Medical Center researchers, supported by the National Institutes of Health (NIH), are leading a nationwide clinical trial to explore the safety and effectiveness of a group of novel drugs designed to protect patients hospitalized with COVID-19 at high risk of poor outcomes.
By Craig Boerner
1 … 4 5 6 7 8 … 19